Experts call for better trials and teamwork to advance transcatheter valve treatment for heart failure-related valve disease.
Interventional Cardiology
Advertisement
CTA-first screening before TAVR avoids invasive angiography in 53% of patients—without compromising outcomes.
Delays in TAVI for acute decompensated aortic stenosis worsen outcomes.
First surgical removal of a Harmony valve due to endocarditis reveals complex challenges and implications.
NAVULTRA registry compares Navitor vs. SAPIEN 3 Ultra in TAVR, revealing key tradeoffs in pacemaker use, PVL, and HF outcomes
The FDA approved the use of Edwards Lifesciences' SAPIEN 3 TAVR platform for patients with severe aortic stenosis.
Dr. Amit Goyal of the CardioNerds analyzed the BHF PROTECT-TAVI trial.
Advertisement
Expert Interviews
Cardio Care Today delivers the latest medical industry news, giving health care professionals the curated content most relevant to their fields and practices.
Get the latest medical updates and insights straight to your inbox.